Go to
JCI Insight
Citations to this article
Mahadeo A. Sukhai, … , Guri Giaever, Aaron D. Schimmer
Published December 3, 2012
Citation Information: J Clin Invest. 2013;123(1):315-328. https://doi.org/10.1172/JCI64180.
Citation Information: J Clin Invest. 2013;123(1):315-328. https://doi.org/10.1172/JCI64180.
Abstract
Despite efforts to understand and treat acute myeloid leukemia (AML), there remains a need for more comprehensive therapies to prevent AML-associated relapses. To identify new therapeutic strategies for AML, we screened a library of on- and off-patent drugs and identified the antimalarial agent mefloquine as a compound that selectively kills AML cells and AML stem cells in a panel of leukemia cell lines and in mice. Using a yeast genome-wide functional screen for mefloquine sensitizers, we identified genes associated with the yeast vacuole, the homolog of the mammalian lysosome. Consistent with this, we determined that mefloquine disrupts lysosomes, directly permeabilizes the lysosome membrane, and releases cathepsins into the cytosol. Knockdown of the lysosomal membrane proteins LAMP1 and LAMP2 resulted in decreased cell viability, as did treatment of AML cells with known lysosome disrupters. Highlighting a potential therapeutic rationale for this strategy, leukemic cells had significantly larger lysosomes compared with normal cells, and leukemia-initiating cells overexpressed lysosomal biogenesis genes. These results demonstrate that lysosomal disruption preferentially targets AML cells and AML progenitor cells, providing a rationale for testing lysosomal disruption as a novel therapeutic strategy for AML.
Authors
Mahadeo A. Sukhai, Swayam Prabha, Rose Hurren, Angela C. Rutledge, Anna Y. Lee, Shrivani Sriskanthadevan, Hong Sun, Xiaoming Wang, Marko Skrtic, Ayesh Seneviratne, Maria Cusimano, Bozhena Jhas, Marcela Gronda, Neil MacLean, Eunice E. Cho, Paul A. Spagnuolo, Sumaiya Sharmeen, Marinella Gebbia, Malene Urbanus, Kolja Eppert, Dilan Dissanayake, Alexia Jonet, Alexandra Dassonville-Klimpt, Xiaoming Li, Alessandro Datti, Pamela S. Ohashi, Jeff Wrana, Ian Rogers, Pascal Sonnet, William Y. Ellis, Seth J. Corey, Connie Eaves, Mark D. Minden, Jean C.Y. Wang, John E. Dick, Corey Nislow, Guri Giaever, Aaron D. Schimmer
Total citations by year
Citation information
Citations to this article (81)
| Title and authors | Publication | Year |
|---|---|---|
|
Endolysosome-targeted nanoparticle delivery of antiviral therapy for coronavirus infections
Petcherski A, Tingley BM, Martin A, Adams S, Brownstein AJ, Steinberg RA, Shabane B, Ngo J, Osto C, Garcia G Jr, Veliova M, Arumugaswami V, Colby AH, Shirihai OS, Grinstaff MW |
Life Science Alliance | 2025 |
|
Machine learning-based bulk RNA analysis reveals a prognostic signature of 13 cell death patterns and potential therapeutic target of SMAD3 in acute myeloid leukemia
Bao X, Chen Y, Chang J, Du J, Yang C, Wu Y, Sha Y, Li M, Chen S, Yang M, Liu SB |
BMC Cancer | 2025 |
|
Lysosome targeted therapies in hematological malignancies
Manivannan MS, Peters A, Gibson SB |
Frontiers in Oncology | 2025 |
|
Cationic amphiphilic drugs induce accumulation of cytolytic lysoglycerophospholipids in the lysosomes of cancer cells and block their recycling into common membrane glycerophospholipids
Nielsen IØ, Clemmensen KK, Fogde DL, Dietrich TN, Giacobini JD, Bilgin M, Jäättelä M, Maeda K |
Molecular biology of the cell | 2024 |
|
Associations of serum cystatin C concentrations with total mortality and mortality of 12 site-specific cancers.
Huang C, Lu J, Yang J, Wang Z, Hang D, Fu Z |
Frontiers in Molecular Biosciences | 2024 |
|
Deregulation of New Cell Death Mechanisms in Leukemia
Favale G, Donnarumma F, Capone V, Della Torre L, Beato A, Carannante D, Verrilli G, Nawaz A, Grimaldi F, De Simone MC, Del Gaudio N, Megchelenbrink WL, Caraglia M, Benedetti R, Altucci L, Carafa V |
Cancers | 2024 |
|
Lysosomal cation channel TRPML1 suppression sensitizes acute myeloid leukemia cells to chemotherapeutics by inhibiting autophagy.
Dai M, Lin B, Li H, Wang Y, Wu M, Wei Y, Zeng W, Qu L, Cang C, Wang X |
Molecular and cellular biochemistry | 2024 |
|
Targeting Lysosomes: A Strategy Against Chemoresistance in Cancer.
Shirbhate E, Singh V, Mishra A, Jahoriya V, Veerasamy R, Tiwari AK, Rajak H |
Mini reviews in medicinal chemistry | 2024 |
|
Progress in the study of mefloquine as an antibiotic adjuvant for combination bacterial inhibition treatment
Liang X, Liu Z, Wang Y, Zhang Y, Deng W, Liu Q, Lu Z, Li K, Chang Y, Wei L |
Frontiers in Cellular and Infection Microbiology | 2024 |
|
Lysosomal damage due to cholesterol accumulation triggers immunogenic cell death
Alvarez-Valadez K, Sauvat A, Diharce J, Leduc M, Stoll G, Guittat L, Lambertucci F, Paillet J, Motiño O, Ferret L, Muller A, Forveille S, Maiuri MC, Kepp O, de Brevern AG, Wodrich H, Pol JG, Kroemer G, Djavaheri-Mergny M |
Autophagy | 2024 |
|
Autolysosomal activation combined with lysosomal destabilization efficiently targets myeloid leukemia cells for cell death
Shah H, Stankov M, Panayotova-Dimitrova D, Yazdi A, Budida R, Klusmann JH, Behrens GM |
Frontiers in Oncology | 2023 |
|
Cationic amphiphilic antihistamines inhibit STAT3 via Ca(2+)-dependent lysosomal H(+) efflux.
Liu B, Chen R, Zhang Y, Huang J, Luo Y, Rosthøj S, Zhao C, Jäättelä M |
Cell Reports | 2023 |
|
A Novel Family of Lysosomotropic Tetracyclic Compounds for Treating Leukemia.
Carbó JM, Cornet-Masana JM, Cuesta-Casanovas L, Delgado-Martínez J, Banús-Mulet A, Clément-Demange L, Serra C, Catena J, Llebaria A, Esteve J, Risueño RM |
Cancers | 2023 |
|
Emerging drugs targeting cellular redox homeostasis to eliminate acute myeloid leukemia stem cells
Costa RG, Silva SL, Dias IR, Oliveira MD, Rodrigues AC, Dias RB, Bezerra DP |
Redox Biology | 2023 |
|
Identification of PPT1 as a lysosomal core gene with prognostic value in hepatocellular carcinoma.
Tian W, Li C, Ren J, Li P, Zhao J, Li S, Dong D |
Bioscience Reports | 2023 |
|
LAMP1/2 as potential diagnostic and prognostic marker for brain lower grade glioma: A review.
Qiu XF, Chen X |
Medicine | 2023 |
|
Hexamethylene amiloride synergizes with venetoclax to induce lysosome-dependent cell death in acute myeloid leukemia
Jiang X, Huang K, Sun X, Li Y, Hua L, Liu F, Huang R, Du J, Zeng H |
iScience | 2023 |
|
Lysosomes at the Crossroads of Cell Metabolism, Cell Cycle, and Stemness
A Nowosad, A Besson |
International journal of molecular sciences | 2022 |
|
Lysosomes in Stem Cell Quiescence: A Potential Therapeutic Target in Acute Myeloid Leukemia
V Jain, S Bose, A Arya, T Arif |
Cancers | 2022 |
|
Identification of Kic1p and Cdc42p as Novel Targets to Engineer Yeast Acetic Acid Stress Tolerance
H Chen, Q Xing, C Cheng, M Zhang, C Liu, V Champreda, X Zhao |
Frontiers in Bioengineering and Biotechnology | 2022 |
|
Anticancer Activity of Natural and Semi-Synthetic Drimane and Coloratane Sesquiterpenoids
L Beckmann, U Tretbar, R Kitte, M Tretbar |
Molecules (Basel, Switzerland) | 2022 |
|
Lysosome-mediated chemoresistance in acute myeloid leukemia
L Cuesta-Casanovas, J Delgado-Martínez, J Cornet-Masana, J Carbó, L Clément-Demange, R Risueño |
2022 | |
|
Hypoxia Induces Autophagy in Human Dendritic Cells: Involvement of Class III PI3K/Vps34
Monaci S, Coppola F, Rossi D, Giuntini G, Filippi I, Marotta G, Sozzani S, Carraro F, Naldini A |
Cells | 2022 |
|
Mefloquine induces ER stress and apoptosis in BRAFi-resistant A375-BRAFV600E/NRASQ61K malignant melanoma cells targeting intracranial tumors in a bioluminescent murine model
Jandova J, Park SL, Corenblum MJ, Madhavan L, Snell JA, Rounds L, Wondrak GT |
Molecular Carcinogenesis | 2022 |
|
Autophagy and organelle homeostasis in cancer
DR Miller, A Thorburn |
Developmental Cell | 2021 |
|
Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?
C Pfab, L Schnobrich, S Eldnasoury, A Gessner, N El-Najjar |
Cancers | 2021 |
|
Novel Approaches of Dysregulating Lysosome Functions in Cancer Cells by Specific Drugs and Its Nanoformulations: A Smart Approach of Modern Therapeutics
KS Allemailem, A Almatroudi, F Alrumaihi, SA Almatroodi, MO Alkurbi, GT Basfar, AH Rahmani, AA Khan |
International Journal of Nanomedicine | 2021 |
|
Lysosomes in acute myeloid leukemia: potential therapeutic targets?
S Rafiq, SL McKenna, S Muller, MP Tschan, M Humbert |
Leukemia | 2021 |
|
Lysosomes and Cancer Progression: A Malignant Liaison
ER Machado, I Annunziata, D van de Vlekkert, GC Grosveld, A dAzzo |
Frontiers in Cell and Developmental Biology | 2021 |
|
Chemical hybridization of sulfasalazine and dihydroartemisinin promotes brain tumor cell death
A Ackermann, A Çapcı, M Buchfelder, SB Tsogoeva, N Savaskan |
Scientific Reports | 2021 |
|
Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax
BS Moses, S McCullough, JM Fox, BT Mott, SM Bentzen, MJ Kim, JW Tyner, RG Lapidus, A Emadi, MA Rudek, TJ Kingsbury, CI Civin |
Blood Advances | 2021 |
|
Endolysosomal TRPMLs in Cancer
M Xu, XP Dong |
Biomolecules | 2021 |
|
Cholesterol-associated lysosomal disorder triggers cell death of hematological malignancy: Dynamic analysis on cytotoxic effects of LW-218
P Hu, H Li, W Sun, H Wang, X Yu, Y Qing, Z Wang, M Zhu, J Xu, Q Guo, H Hui |
Acta pharmaceutica Sinica. B | 2021 |
|
FV-429 induces autophagy blockage and lysosome-dependent cell death of T-cell malignancies via lysosomal dysregulation
P Hu, J Wang, Y Qing, H Li, W Sun, X Yu, H Hui, Q Guo, J Xu |
Cell Death and Disease | 2021 |
|
Natural Products Induce Lysosomal Membrane Permeabilization as an Anticancer Strategy
R Halaby |
Medicines | 2021 |
|
Hepatic small extracellular vesicles promote microvascular endothelial hyperpermeability during NAFLD via novel-miRNA-7
R Zuo, LF Ye, Y Huang, ZQ Song, L Wang, H Zhi, MY Zhang, JY Li, L Zhu, WJ Xiao, HC Shang, Y Zhang, RR He, Y Chen |
Journal of nanobiotechnology | 2021 |
|
GNS561, a New Autophagy Inhibitor Active against Cancer Stem Cells in Hepatocellular Carcinoma and Hepatic Metastasis from Colorectal Cancer
S Brun, JM Pascussi, EP Gifu, E Bestion, Z Macek-Jilkova, G Wang, F Bassissi, S Mezouar, J Courcambeck, P Merle, T Decaens, J Pannequin, P Halfon, CC de Fromentel |
Journal of Cancer | 2021 |
|
Cationic amphiphilic drugs as potential anticancer therapy for bladder cancer
G Horst, AF Merbel, E Ruigrok, MH Mark, E Ploeg, L Appelman, S Tvingsholm, M Jäätelä, J Uhm, MK Julio, GN Thalmann, RC Pelger, CH Bangma, JL Boormans, G Pluijm, EC Zwarthoff |
Molecular Oncology | 2020 |
|
Has Drug Repurposing Fulfilled Its Promise in Acute Myeloid Leukaemia?
D Valli, AM Gruszka, M Alcalay |
Journal of Clinical Medicine | 2020 |
|
Somatostatin receptor mediated targeting of acute myeloid leukemia by photodynamic metal complexes for light induced apoptosis
NM Vegi, S Chakrabortty, MM Zegota, SL Kuan, A Stumper, VP Rawat, S Sieste, C Buske, S Rau, T Weil, M Feuring-Buske |
Scientific Reports | 2020 |
|
Derivatives of the Antimalarial Drug Mefloquine Are Broad-Spectrum Antifungal Molecules with Activity against Drug-Resistant Clinical Isolates
MC Montoya, S Beattie, KM Alden, DJ Krysan |
Antimicrobial agents and chemotherapy | 2020 |
|
Induction of Lysosome Membrane Permeabilization as a Therapeutic Strategy to Target Pancreatic Cancer Stem Cells
TP Cash, S Alcalá, M del Rosario Rico-Ferreira, E Hernández-Encinas, J García, MI Albarrán, S Valle, J Muñoz, S Martínez-González, C Blanco-Aparicio, Joaquín, M Serrano, B Sainz |
Cancers | 2020 |
|
Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas
F Mudassar, H Shen, G ONeill, E Hau |
Journal of Experimental & Clinical Cancer Research | 2020 |
|
Making Connections: p53 and the Cathepsin Proteases as Co-Regulators of Cancer and Apoptosis
SM Soond, LV Savvateeva, VA Makarov, NV Gorokhovets, PA Townsend, AA Zamyatnin |
Cancers | 2020 |
|
Getting Lost in the Cell–Lysosomal Entrapment of Chemotherapeutics
X Zhai, YE Hiani |
Cancers | 2020 |
|
Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia
S Pei, DA Pollyea, A Gustafson, BM Stevens, M Minhajuddin, R Fu, KA Riemondy, AE Gillen, RM Sheridan, J Kim, JC Costello, ML Amaya, A Inguva, A Winters, H Ye, A Krug, CL Jones, B Adane, N Khan, J Ponder, J Schowinsky, D Abbott, A Hammes, JR Myers, JM Ashton, T Nemkov, A D'Alessandro, JA Gutman, HE Ramsey, MR Savona, CA Smith, CT Jordan |
Cancer Discovery | 2020 |
|
Dual lysosomal-mitochondrial targeting by antihistamines to eradicate leukaemic cells
JM Cornet-Masana, A Banús-Mulet, JM Carbó, MÁ Torrente, F Guijarro, L Cuesta-Casanovas, J Esteve, RM Risueño |
EBioMedicine | 2019 |
|
Lysosome Inhibition by Mefloquine Preferentially Enhances the Cytotoxic Effects of Tyrosine Kinase Inhibitors in Blast Phase Chronic Myeloid Leukemia
HL Yi, H Than, C Sng, MA Cheong, C Chuah, W Xiang |
Translational oncology | 2019 |
|
Gata2 as a Crucial Regulator of Stem Cells in Adult Hematopoiesis and Acute Myeloid Leukemia
JB Menendez-Gonzalez, M Vukovic, A Abdelfattah, L Saleh, A Almotiri, L Thomas, A Agirre-Lizaso, A Azevedo, AC Menezes, G Tornillo, S Edkins, K Kong, P Giles, F Anjos-Afonso, A Tonks, AS Boyd, KR Kranc, NP Rodrigues |
Stem Cell Reports | 2019 |
|
Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia
BM Barth, W Wang, PT Toran, TE Fox, C Annageldiyev, RM Ondrasik, NR Keasey, TJ Brown, VG Devine, EC Sullivan, AL Cote, V Papakotsi, SF Tan, SS Shanmugavelandy, TG Deering, DB Needle, ST Stern, J Zhu, J Liao, AD Viny, DJ Feith, RL Levine, HG Wang, TP Loughran, A Sharma, M Kester, DF Claxton |
Blood Advances | 2019 |
|
Therapeutic targeting of the PI4K2A/PKR lysosome network is critical for misfolded protein clearance and survival in cancer cells
A Pataer, B Ozpolat, RP Shao, NR Cashman, SS Plotkin, CE Samuel, SH Lin, NN Kabil, J Wang, M Majidi, B Fang, JA Roth, AA Vaporciyan, II Wistuba, MC Hung, SG Swisher |
Oncogene | 2019 |
|
Antihistamines and Ovarian Cancer Survival: Nationwide Cohort Study and in Vitro Cell Viability Assay
F Verdoodt, C Dehlendorff, M Jäättelä, R Strauss, A Pottegård, J Hallas, S Friis, SK Kjaer |
JNCI Journal of the National Cancer Institute | 2019 |
|
Cell Death Induced by Cationic Amphiphilic Drugs Depends on Lysosomal Ca 2+ Release and Cyclic AMP
A Anand, B Liu, JD Giacobini, K Maeda, M Rohde, M Jäättelä |
Molecular cancer therapeutics | 2019 |
|
Typical and Atypical Inducers of Lysosomal Cell Death: A Promising Anticancer Strategy
A Domagala, K Fidyt, M Bobrowicz, J Stachura, K Szczygiel, M Firczuk |
International journal of molecular sciences | 2018 |
|
C. elegans-based screen identifies lysosome-damaging alkaloids that induce STAT3-dependent lysosomal cell death
Y Li, Y Zhang, Q Gan, M Xu, X Ding, G Tang, J Liang, K Liu, X Liu, X Wang, L Guo, Z Gao, X Hao, C Yang |
Protein & Cell | 2018 |
|
Enhancing lysosomal biogenesis and autophagic flux by activating the transcription factor EB protects against cadmium-induced neurotoxicity
H Pi, M Li, L Tian, Z Yang, Z Yu, Z Zhou |
Scientific Reports | 2017 |
|
Lysosomes as Oxidative Targets for Cancer Therapy
RF Dielschneider, ES Henson, SB Gibson |
Oxidative medicine and cellular longevity | 2017 |
|
Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells
M Circu, J Cardelli, M Barr, K OByrne, G Mills, H El-Osta, V Trajkovic |
PloS one | 2017 |
|
Cytotoxic profiling of artesunic and betulinic acids and their synthetic hybrid compound on neurons and gliomas
A Ackermann, AÇ Karagöz, A Ghoochani, M Buchfelder, I Eyüpoglu, SB Tsogoeva, N Savaskan |
Oncotarget | 2017 |
|
Obatoclax kills anaplastic thyroid cancer cells by inducing lysosome neutralization and necrosis
D Champa, A Orlacchio, B Patel, M Ranieri, AA Shemetov, VV Verkhusha, AM Cuervo, AD Cristofano |
Oncotarget | 2016 |
|
Interferon-stimulated gene 15 induces cancer cell death by suppressing the NF-κB signaling pathway
H Mao, M Wang, B Cao, H Zhou, Z Zhang, X Mao |
Oncotarget | 2016 |
|
Evaluation of artemisinins for the treatment of acute myeloid leukemia
CD Drenberg, J Buaboonnam, SJ Orwick, S Hu, L Li, Y Fan, AA Shelat, RK Guy, J Rubnitz, SD Baker |
Cancer Chemotherapy and Pharmacology | 2016 |
|
GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways
L Guerenne, S Beurlet, M Said, P Gorombei, CL Pogam, F Guidez, P la Grange, N Omidvar, V Vanneaux, K Mills, GJ Mufti, L Sarda-Mantel, ME Noguera, M Pla, P Fenaux, RA Padua, C Chomienne, P Krief |
Journal of Hematology & Oncology | 2016 |
|
Repurposing Cationic Amphiphilic Antihistamines for Cancer Treatment
AM Ellegaard, C Dehlendorff, AC Vind, A Anand, L Cederkvist, NH Petersen, J Nylandsted, J Stenvang, A Mellemgaard, K Østerlind, S Friis, M Jäättelä |
EBioMedicine | 2016 |
|
A Novel High Content Imaging-Based Screen Identifies the Anti-Helminthic Niclosamide as an Inhibitor of Lysosome Anterograde Trafficking and Prostate Cancer Cell Invasion
ML Circu, SS Dykes, J Carroll, K Kelly, F Galiano, A Greer, J Cardelli, H El-Osta, S Yu |
PloS one | 2016 |
|
Tumor acidosis enhances cytotoxic effects and autophagy inhibition by salinomycin on cancer cell lines and cancer stem cells
P Pellegrini, M Dyczynski, FV Sbrana, M Karlgren, M Buoncervello, M Hägg-Olofsson, R Ma, J Hartman, S Bajalica-Lagercrantz, D Grander, P Kharaziha, AD Milito |
Oncotarget | 2016 |
|
Derivatives of 6-cinnamamido-quinoline-4-carboxamide impair lysosome function and induce apoptosis
HH Kuo, R Kakadiya, YC Wu, TL Su, TC Lee, YW Lin, LH Yih |
Oncotarget | 2016 |
|
Discovery of Small Molecules That Induce Lysosomal Cell Death in Cancer Cell Lines Using an Image-Based Screening Platform
RJ Pagliero, DS D'Astolfo, D Lelieveld, RD Pratiwi, S Aits, M Jaattela, NI Martin, J Klumperman, DA Egan |
ASSAY and Drug Development Technologies | 2016 |
|
Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response
OC Olson, JA Joyce |
Nature Reviews Cancer | 2015 |
|
Cross-cancer profiling of molecular alterations within the human autophagy interaction network
CB Lebovitz, AG Robertson, R Goya, SJ Jones, RD Morin, MA Marra, SM Gorski |
Autophagy | 2015 |
|
Lysosomotropic agents selectively target chronic lymphocytic leukemia cells due to altered sphingolipid metabolism
RF Dielschneider, H Eisenstat, S Mi, JM Curtis, W Xiao, JB Johnston, SB Gibson |
Leukemia | 2015 |
|
Anti-leukemic effects of the V-ATPase inhibitor Archazolid A.
Zhang S, Schneider LS, Vick B, Grunert M, Jeremias I, Menche D, Müller R, Vollmar AM, Liebl J |
Oncotarget | 2015 |
|
Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells
Eling N, Reuter L, Hazin J, Hamacher-Brady A, Brady NR |
Oncoscience | 2015 |
|
Lysosomal drug sequestration as a mechanism of drug resistance in vascular sarcoma cells marked by high CSF-1R expression
Brandi H Gorden, Jhuma Saha, Ali Khammanivong, Gary K Schwartz, Erin B Dickerson |
Vascular cell | 2014 |
|
Reactive oxygen species in eradicating acute myeloid leukemic stem cells
Hui Zhang, Hai Fang, Kankan Wang |
Stem Cell Investigation | 2014 |
|
Identification of novel pathogenic copy number aberrations in multiple myeloma: the Malaysian context
PI Bong, C Ng, K Lam, PJ Baharuddin, K Chang, Z Zakaria |
Molecular cytogenetics | 2014 |
|
Automatic context-specific subnetwork discovery from large interaction networks
A Saha, AC Tan, J Kang |
PloS one | 2014 |
|
Myeloproliferative neoplasms can be initiated from a single hematopoietic stem cell expressing JAK2-V617F
P Lundberg, H Takizawa, L Kubovcakova, G Guo, H Hao-Shen, S Dirnhofer, SH Orkin, MG Manz, RC Skoda |
Journal of Experimental Medicine | 2014 |
|
Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance
Zhitomirsky B, Assaraf YG |
Oncotarget | 2014 |
|
The antimalarial amodiaquine causes autophagic-lysosomal and proliferative blockade sensitizing human melanoma cells to starvation- and chemotherapy-induced cell death
S Qiao, S Tao, MR de la Vega, SL Park, AA Vonderfecht, SL Jacobs, DD Zhang, GT Wondrak |
Autophagy | 2013 |
|
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)